Plus Therapeutics Inc
(PSTV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 5,824 | 4,913 | 224 | 0 | 303 |
| Gross Profit | 5,824 | 4,913 | 224 | N/A | 303 |
| Operating Expenses | 20,519 | 18,234 | 19,936 | 12,492 | 9,887 |
| Operating Income | -14,695 | -13,321 | -19,712 | -12,492 | -9,584 |
| Interest Expense | 179 | 395 | 711 | 932 | 1,107 |
| Other Income | 1,896 | 400 | 148 | 25 | 2,450 |
| Pre-tax Income | -12,978 | -13,316 | -20,275 | -13,399 | -8,241 |
| Net Income Continuous | -12,978 | -13,316 | -20,275 | -13,399 | -8,241 |
| Net Income | $-12,978 | $-13,316 | $-20,275 | $-13,399 | $-8,241 |
| EPS Basic Total Ops | -1.95 | -4.24 | -11.58 | -16.64 | -27.89 |
| EPS Basic Continuous Ops | -1.95 | -4.24 | -11.59 | -16.62 | -27.90 |
| EPS Diluted Total Ops | -2.34 | -4.24 | -11.58 | -16.64 | -27.89 |
| EPS Diluted Continuous Ops | -1.69 | -4.24 | -11.59 | -16.62 | -27.90 |
| EPS Diluted Before Non-Recurring Items | -2.43 | -4.24 | -173.08 | -249.50 | -418.08 |
| EBITDA(a) | $-13,952 | $-12,503 | $-18,704 | $-11,551 | $-8,634 |